PI
MNTA

Putnam Investments’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Putnam Investments’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-275,600
Closed -$9.17M – 943
2020
Q2 		$9.17M Buy
+275,600
New +$8.78M 0.02% 341
2019
Q4 		– Sell
-248,200
Closed -$3.22M – 962
2019
Q3 		$3.22M Sell
248,200
-321,800
-56% -$3.89M 0.01% 614
2019
Q2 		$7.1M Hold
570,000
– – 0.02% 442
2019
Q1 		$8.28M Buy
570,000
+251,100
+79% +$3.21M 0.02% 388
2018
Q4 		$3.52M Buy
318,900
+63,900
+25% +$889K 0.01% 535
2018
Q3 		$6.71M Buy
+255,000
New +$6.89M 0.01% 479

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Putnam Investments's MNTA Position: Q3 2020 in Review

Putnam Investments sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 275,600 shares — an estimated $9.17M sold.

Putnam Investments first reported a position in MNTA in Q3 2018 and held it in 6 quarters. The position peaked at $9.17M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Putnam Investments reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Putnam Investments sold 275,600 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $9.17M.
  • Putnam Investments first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2018 and held it in 6 quarters.
  • Putnam Investments's Momenta Pharmaceuticals, Inc. position peaked at $9.17M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Putnam Investments's 13F filing for Q3 2020, filed 16 Nov 2020.